NanoInk this week launched its NanoArray Assay System for the automated analysis of its protein NanoArray assays.
According to the Skokie, Ill.-based firm, the system enables the detection, identification, and quantitation of clinically relevant, low abundance proteins from a wide variety of sample types for applications such as biomarker analysis, translational medicine, and toxicology.
The desktop unit can create reproducible protein arrays over millimeter areas and then can fluorescently image these arrays with 0.5 nanometer resolution, according to the firm.
The company also claims that the platform can achieve sub-picogram sensitivities with 2 nanoliters or less of sample.